Frank Karbe - Apr 10, 2023 Form 4 Insider Report for Better Therapeutics, Inc. (BTTX)

Role
Chief Executive Officer, President, Treasurer and Secretary, Director
Signature
/s/ Mark Heinen, Attorney-in-Fact
Stock symbol
BTTX
Transactions as of
Apr 10, 2023
Transactions value $
$200,000
Form type
4
Date filed
4/12/2023, 04:15 PM
Previous filing
Sep 15, 2022
Next filing
May 30, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BTTX Common Stock Purchase $200K +242K +484.85% $0.83 292K Apr 10, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On April 6, 2023, the Issuer entered into a Securities Purchase Agreement with certain investors (the "PIPE Investors") in a private placement offering, pursuant to which the PIPE Investors agreed to purchase shares of Issuer common stock for $0.825 per share. As one of the PIPE Investors, the Reporting Person acquired 242,424 shares of Issuer common stock on April 10, 2023 for $0.825 per share.

Remarks:

Chief Executive Officer, President, Treasurer and Secretary